<DOC>
	<DOCNO>NCT01237275</DOCNO>
	<brief_summary>First , investigator examine functional relevance serotonin transporter polymorphisms quantify activity serotonin transporter blood platelet genotyped healthy volunteer patient major depression . Second , investigator study response SSRIs relation 5-HTTLPR genotype also functional expression 5-HTT platelet .</brief_summary>
	<brief_title>Development A Technique Predict Antidepressant Responsiveness Depressive Patients</brief_title>
	<detailed_description>The purpose study 1. determine whether serotonin transporter genotypic functional difference depressive patient normal control exist . 2. determine relationship serotonin transporter polymorphisms serotonin transporter functional expression . 3. determine whether genomic functional difference drug responder nonresponders predict response antidepressant</detailed_description>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Eligible patient enrol clinical trial program hte Samsung Medical Center Geropsychiatry Affective Disorder Clinics ( Seoul , Korea ) . They receive semistructured diagnostic interview , Samsung Psychiatric Evaluation Schedule . The affective disorder section Samsung Psychiatric Evaluation Schedule use Korean version structure clinical interview diagnostic statistical manual mental disorder , Fourth edition . interview one patient 's family member objective diagnosis final diagnosis decision agreement two psychiatric physician receive psychotropic medication within 2 week study fluoxetine within 4 week potential study participant pregnancy , significant medical condition , abnormal laboratory baseline value , unstable psychiatric feature ( eg.suicidal ) , history alcohol drug dependence , seizure , head trauma loss consciousness , neurological illness , concomitant Axis I psychiatric disorder .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pharmacogenomics</keyword>
	<keyword>Prediction Antidepressant Response</keyword>
	<keyword>Depressed Patients</keyword>
</DOC>